The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

The partnership has enabled Viralgen to scale up and complete a GMP trial material batch of Trogenix's therapy.

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Hualong ...

The Team from Huazhong University of Science and Technology Reveals the Electro-Optic Effect Mechanism and Future ...

The fight against neglected tropical diseases is a fight for equity, productivity and long-term security. Southeast Asia can ...

Navitas' valuation has surged well above sector peers, lowering the opportunity for near-term upside. Click here to find out ...

Opinion Linus Torvalds is the global hero most of the world doesn't even know exists. There are no big movies about him, no ...

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting ...